Skip to content

Crocin in acute kidney injury

Evaluation of Crocin effect on the contrast induced nephropathy following coronary angiography or angioplasty: A randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200202046335N1
Enrollment
100
Registered
2020-05-13
Start date
2019-08-29
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast induced nephropathy. Nephropathy induced by other drugs, medicaments and biological substances

Interventions

Intervention 1: Intervention group: 3 consecutive oral doses of 30 mg crocina brand tablets. before and 24 and 48 hrs after PCI. of note is that since crocina tablets are 15 mg, each time the patient

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Undergoing coronary or peripheral angiography with or without intervention Cr > 1.2 mg/dL and 30 <GFR < 60 mL/min Systolic pressure of greater than 90 mm Hg No contraindications to hydration or contrast agent

Exclusion criteria

Exclusion criteria: History of hypersensitivity to saffron End-stage renal disease on dialysis Acute renal failure Pregnancy or lactation Emergent coronary angiography, ST elevation myocardial infarction (STEMI), or cardiogenic shock Patient receiving N-acetylcysteine or sodium bicarbonate Platelets less than or equal to 100,000/mm3 Left Ventricular ejection fraction less than 30 History of Kidney transplant

Design outcomes

Primary

MeasureTime frame
BUN & Creatinin. Timepoint: Before intervention and 24 and 72 hrs after that. Method of measurement: blood urine nitrogen and creatinine lab test.;(NGAL)Neutrophilic Gelatinase Associated Lipocaline. Timepoint: before and 8 hrs after angiography. Method of measurement: urine sample collection in urine sample containers.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Esfandyari

Kermanshah University of Medical Sciences

esfandyarishyma@gmail.com+98 83 3843 8310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026